Ask AI
New Directions With PARPis
New Directions With PARP Inhibitors in Pancreatic Cancer

Released: February 21, 2022

Expiration: February 20, 2023

Activity

In this episode, Eileen M. O’Reilly, MD, and Naureen Starling, MD, FRCP,  discuss emerging therapeutic strategies involving PARP inhibitor therapy in the treatment of pancreatic cancer. Topics include:

  • Current treatment landscape and testing in the United States vs the United Kingdom  
  • Testing for molecular subgroups beyond BRCAm
  • Using PARP inhibitors in earlier stages of the disease
  • Learning from other cancers, such as prostate, breast, and ovarian